From: Imaging of COVID-19-associated rhino-orbital-cerebral mucormycosis: imaging analysis of 120 patients
T1-weighted imaging | ||
 Isointense/hypointense | 120 | 100% |
T2-weighted imaging | ||
 Isointense/hypointense | 39 | 32.50% |
 Heterogenous | 58 | 48.33% |
 Hyperintense | 23 | 19.67% |
Enhancement pattern | ||
 Intense homogenous | 5 | 4.17% |
 Heterogenous | 20 | 16.67% |
 Central non-enhancement with peripheral enhancement | 88 | 73.33% |
 Complete non-enhancement | 7 | 5.83% |